CABG vs. PCI in Patients With DM, Multivessel CAD, and CKD CABG vs. PCI in Patients With DM, Multivessel CAD, and CKD
What's the optimal method of coronary revascularization among patients with diabetes mellitus and multivessel CAD complicated by chronic kidney disease?European Heart Journal (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - February 20, 2017 Category: Surgery Tags: Cardiology Journal Article Source Type: news

Cutting Salt a Health Boost for Kidney Patients
Blood pressure and fluid retention improve in those counseled by dietitians, small study shows Source: HealthDay Related MedlinePlus Pages: Chronic Kidney Disease, Sodium (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 17, 2017 Category: Consumer Health News Source Type: news

How to improve the 'health literacy' of parents caring for kids with chronic kidney disease
A study out of Sick Kids underscores the value of reinforcing training to parents after their child is diagnosed with chronic kidney illness. (Source: CBC | Health)
Source: CBC | Health - February 17, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Catheter Ablation of AF in Patients With CKD Catheter Ablation of AF in Patients With CKD
Do patients with chronic kidney disease who undergo catheter ablation for atrial fibrillation suffer more postprocedural complications or worse outcomes than those with normal kidney function?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 17, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Study finds genetic links with kidney injury
Cases of acute kidney injury (AKI) in hospitals are on the rise but treatments are elusive. To deepen understanding of the condition, which can lead to chronic kidney disease or death, a Yale-led research team conducted the largest study of genes associated with AKI to date. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 16, 2017 Category: Universities & Medical Training Tags: Yale News Source Type: news

Reducing Cardiovascular Mortality in Kidney Disease: Time to Focus on Heart Failure? Reducing Cardiovascular Mortality in Kidney Disease: Time to Focus on Heart Failure?
Dr Bansal discusses several key clinical trials examining cardiovascular disease risk in patients with chronic kidney disease.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 10, 2017 Category: Consumer Health News Tags: Nephrology Article Source Type: news

US FDA approves Amgen ’s Parsabiv to treat HPT in adult patients
The US Food and Drug Administration (FDA) has approved Amgen ’s Parsabiv (etelcalcetide) to treat secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on haemodialysis. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 9, 2017 Category: Pharmaceuticals Source Type: news

FDA approves Amgen drug for secondary hyperparathyroidism
(Reuters) - The U.S. Food and Drug Administration has approved Amgen Inc's treatment for secondary hyperparathyroidism in adult patients with chronic kidney disease undergoing dialysis, the U.S. biotech company said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Amgen's Parsabiv ™ (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis
Intravenous Administration Puts Delivery in Hands of Healthcare Provider THOUSAND OAKS, Calif., Feb. 7, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Parsabiv™ (etelcalcetide) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis. Parsabiv is the first therapy approved for this condition in 12 years and the only calcimimetic that can be administered intravenously by the dialysis health care team three times a week at the end of the hemodialysis session. To view ...
Source: Amgen News Release - February 7, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Mineralocorticoid Antagonists in Chronic Kidney Disease Mineralocorticoid Antagonists in Chronic Kidney Disease
What role do mineralocorticoid receptor antagonists have in the treatment paradigm of CKD?Current Opinion in Nephrology and Hypertension (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Donor dilemma
When her daughter, Thalya, was diagnosed with chronic kidney disease, Chantal Onelien's initial reaction was shock. But, as Adam Harris reports, it was only the beginning of a long and difficult fight. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 6, 2017 Category: Consumer Health News Source Type: news

Skin sodium content linked to heart problems in patients with kidney disease
Elevated sodium content in the skin correlates closely with left ventricular hypertrophy in patients with chronic kidney disease, report researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 3, 2017 Category: Science Source Type: news

IV contrast for CT is not associated with increased risk of acute kidney injury
Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of acute kidney injury following contrast media administration in the emergency department were just published. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 26, 2017 Category: Science Source Type: news

IV contrast for CT is not associated with increased risk of acute kidney injury
(American College of Emergency Physicians) Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of acute kidney injury following contrast media administration in the emergency department were published online yesterday in Annals of Emergency Medicine ('Risk of Acute Kidney Injury Following Intravenous Contrast Media Administration'). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 26, 2017 Category: Global & Universal Source Type: news

Ferric Citrate Improves Iron-Deficiency Anemia in Chronic Kidney Disease Ferric Citrate Improves Iron-Deficiency Anemia in Chronic Kidney Disease
Oral treatment with ferric citrate improves iron-deficiency anemia in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD), according to a randomized controlled trial.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 20, 2017 Category: Intensive Care Tags: Family Medicine/Primary Care News Source Type: news

Statin Use Associated With Benefits in Early-Stage Kidney Disease Statin Use Associated With Benefits in Early-Stage Kidney Disease
Patients with early-stage chronic kidney disease (CKD) who take statins have reduced mortality and a slower decline in kidney function, though this is not true for patients with more advanced disease, new findings show.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 20, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

CKD care has improved but GPs should conduct more urine tests, report says
GPs have helped cut the need for dialysis among patients with chronic kidney disease (CKD) through earlier diagnosis over the last decade, but greater use of annual urine testing and accurate read coding could boost progress further, according to a clinical audit. (Source: GP Online News)
Source: GP Online News - January 18, 2017 Category: Primary Care Tags: Renal disorders Source Type: news

PAs are Altering the Course of Chronic Kidney Disease
Certified PAs and other healthcare providers can follow this simple assessment protocol to help with early detection of chronic kidney disease. (Source: Physicians Practice)
Source: Physicians Practice - January 17, 2017 Category: Practice Management Authors: Kendra Thomsen, PA-C Tags: Blog CME Staff Tools Source Type: news

Kidney disease patients have higher out-of-pocket costs than stroke and cancer patients
(Loyola University Health System) Patients who have chronic kidney disease but are not on dialysis have higher out-of-pocket healthcare expenses than even stroke and cancer patients, according to a Loyola University Chicago study published in BMC Nephrology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2017 Category: Cancer & Oncology Source Type: news

The Challenges of Treating Cancer Patients on Hemodialysis, or With Chronic Kidney Disease
It is challenging to diagnose, manage, and treat patients who have kidney disease in addition to cancer. Second to cardiovascular disease, cancer represents a major cause of mortality and morbidity in the kidney disease population. (Source: CancerNetwork)
Source: CancerNetwork - January 15, 2017 Category: Cancer & Oncology Authors: Charbel C. Khoury, MD David J. R. Steele, MD Tags: Oncology Journal Source Type: news

Trial finds oral iron drug safe, effective for treating anemia in kidney disease patients
In a phase 3 trial of patients with chronic kidney disease, 52.1% of patients receiving oral ferric citrate experienced a significant boost in hemoglobin levels (a reflection of red blood cell counts) compared with 19.1% of patients receiving placebo. A treatment effect was seen as early as 1-2 weeks after the start of treatment, and the response was durable. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 12, 2017 Category: Science Source Type: news

Having a health check could save your life
Regular health checks – which are commissioned by councils as part of their public health duties - are saving lives across the country by identifying early signs of potentially life-threatening conditions. More new cases of diabetes, hypertension, and chronic kidney disease were identified among attendees than a matche d group of non-attendees. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 11, 2017 Category: Consumer Health News Source Type: news

Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv ™ (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
THOUSAND OAKS, Calif., Jan. 10, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Journal of the American Medical Association (JAMA) publication of findings from three Phase 3 studies of Parsabiv™ (etelcalcetide), an investigational intravenous calcimimetic agent in the U.S. The studies evaluated Parsabiv in more than 1,700 adults with secondary hyperparathyroidism (sHPT) on hemodialysis and showed that the drug produced statistically significant and clinically meaningful reductions in serum parathyroid hormone (PTH) levels, a key marker of sHPT. sHPT is a chronic and serious condition that is often p...
Source: Amgen News Release - January 10, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

' Goldilocks' drug prevents chronic kidney disease in primates
A research team has developed a way to avoid ischemia/reperfusion injury of the kidney with a new monoclonal antibody that binds its target receptor in a way that is'just right.'(Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 10, 2017 Category: Science Source Type: news

Metformin Associated with Lower Mortality Risk in Heart Failure, Chronic Kidney Disease (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Use of metformin is associated with reduced mortality in patients with diabetes plus chronic heart failure (CHF), chronic kidney disease (CKD), or chronic liver disease, according … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 2, 2017 Category: Primary Care Source Type: news

Breast and cervical cancer screening rates are low in women with advanced kidney disease
(American Society of Nephrology) In a recent study, most women with advanced chronic kidney disease had not received breast or cervical cancer screening in recent years. Older age, greater comorbidities, and lower income were associated with a lower rate of screening. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 29, 2016 Category: Global & Universal Source Type: news

Keeping the Resolve in Your New Year's Resolutions
Losing weight is a top New Year's resolution for many Americans. Reaching and staying at a healthy weight are resolutions worth keeping--not just throughout the year, but throughout a lifetime. Avoiding overweight and obesity may help reduce the risk of developing a host of health problems, including diabetes, chronic kidney disease, heart disease, and some types of cancer. With more than 2 in 3 American adults considered overweight or obese, maintaining a healthy weight is a major public health concern. Setting Goals and Creating an Action Plan If you've resolved to lose weight, you're more likely to keep your resoluti...
Source: Healthy Living - The Huffington Post - December 23, 2016 Category: Consumer Health News Source Type: news

HF Risk Outweighs Stroke in Chronic Kidney Disease
(MedPage Today) -- Observed risk particularly high in African Americans and Hispanics (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 21, 2016 Category: Urology & Nephrology Source Type: news

​Cambridge’s Akebia announces deal worth $170M now, maybe over $1B later
Cambridge-based Akebia Therapeutics has announced a collaboration and license agreement in the U.S. for its anemia drug with a Japanese drugmaker under which it will get $160 million in coming months and potentially more than $1 billion in coming years. The agreement between Akebia (Nadsaq: AKBA) and Otsuka Pharmaceutical Co. is related to Akebia’s drug, vadadustat, which is now in development for the treatment of anemia associated with chronic kidney disease. Anemia related to CKD affects an… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 20, 2016 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news

PCI Without Contrast in Advanced Renal Failure PCI Without Contrast in Advanced Renal Failure
The authors report on a novel strategy for safely performing PCI without the use of contrast in patients with advanced chronic kidney disease.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 19, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Protein in urine linked to increased risk of memory problems
Chronic kidney disease and dementia share many risk factors, researchers point out Related items fromOnMedica Constipation linked to kidney disease Dementia now leading cause of death in England and Wales Memory clinic referral criteria delay diagnosis 'Watch and wait' might be better in advanced kidney cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 14, 2016 Category: UK Health Source Type: news

Proteon Therapeutics kidney drug fails key study, shares slump
(Reuters) - Proteon Therapeutics Inc said on Tuesday that its experimental chronic kidney disease drug failed to meet the main goal in a late-stage study, sending its shares plunging 70 percent in premarket trading. (Source: Reuters: Health)
Source: Reuters: Health - December 13, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Cardiovascular complications of renal disease
Aetiology and management of risk factors for cardiovascular disease in patients with chronic kidney disease and the use of beta-blockers, statins, diuretics and anticoagulants in controlling progression of disease. (Source: GP Online Education)
Source: GP Online Education - December 13, 2016 Category: Primary Care Tags: 15.1 Cardiovascular Problems Source Type: news

Bone marrow-derived cells are source of key kidney disease biomarker SuPAR
A protein that is a reliable biomarker for chronic kidney disease originates in the bone marrow, new research suggests. This discovery of where the suPAR protein is an important step towards earlier detection -and possible prevention -- of a disease suffered by one in 10 adults, kills 48,000 people and costs Medicare $49 billion each year (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 12, 2016 Category: Science Source Type: news

Major depression and long-term outcomes of acute kidney injury - Balogun RA, Omotoso BA, Xin W, Ma JZ, Scully KW, Arogundade FA, Abdel-Rahman EM.
This study determines the prognostic implication of a diagnosi... (Source: SafetyLit)
Source: SafetyLit - December 10, 2016 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Healthy Diet May Mean Longer Life for Kidney Patients
Study found eating lots of fruit, vegetables, fish, whole grains was linked to lower rate of early death Source: HealthDay Related MedlinePlus Pages: Chronic Kidney Disease, Nutrition (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 9, 2016 Category: Consumer Health News Source Type: news

Healthy Diet May Mean Longer Life for Kidney Patients
THURSDAY, Dec. 8, 2016 -- A healthy diet may help people with kidney disease live longer, researchers report. They analyzed seven studies that included more than 15,000 people with chronic kidney disease, to assess the effects of a diet high in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 8, 2016 Category: Journals (General) Source Type: news

Kidney disease hospitalization and mortality rates continue to decline in the US
(University of Michigan Health System) According to an annual data report from the United States Renal Data System (USRDS), hospitalization and mortality rates for patients with chronic kidney disease continue to decline in the US. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 2, 2016 Category: Global & Universal Source Type: news

Fetal and Neonatal Renal Failure and Renal Transplant
Major advances have been made over the past few decades in caring for neonates with chronic renal disease. Although dialysis registries report infants as a high-risk population for poor outcomes, these children can be effectively maintained on dialysis until they are ready for receiving a transplant. Early identification of the presence of chronic renal disease is helpful in preparing for postnatal complications and to counsel parents on potential outcomes of infants with chronic kidney disease. (Source: NeoReviews recent issues)
Source: NeoReviews recent issues - November 30, 2016 Category: Pediatrics Authors: Wong, C. J. Tags: Pediatric Drug Labeling Update Complex Fetal Care Source Type: news

Assessing Fluid Status and Physical Function in Patients With CKD Assessing Fluid Status and Physical Function in Patients With CKD
Dr Desai discusses new methods of evaluating body composition and physical function in patients with chronic kidney disease who are not on dialysis.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 28, 2016 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

GSK initiates Phase III programme of daprodustat
UK drug manufacturer GlaxoSmithKline (GSK) has initiated its Phase III programme of daprodustat being developed to treat anaemia associated with chronic kidney disease (CKD). (Source: Drug Development Technology)
Source: Drug Development Technology - November 28, 2016 Category: Pharmaceuticals Source Type: news

Baxter touts blood purification efficiency in EBP studies
Baxter (NYSE:BAX) today released data from 2 studies on extracorporeal blood purification studies, touting the blood purification method’s ability to remove harmful molecules linked to inflammation. Extracorporeal blood purification takes place outside the body, with blood passing through a membrane within an extracorporeal circuit to filter harmful molecules and waste products out of the blood, the company said. The clean blood is then returned to the body. The method is commonly used for patients with kidney injuries. Data from the studies was presented at the American Society of Nephrology’s annual Kidn...
Source: Mass Device - November 22, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Clinical Trials Baxter Source Type: news

Poor Sleep Linked to Worsening Kidney Disease
SATURDAY, Nov. 19, 2016 -- For people with chronic kidney disease, poor sleep may boost the chances that their illness will worsen, new research suggests. " Short sleep and fragmented sleep are significant yet unappreciated risk factors for chronic... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 19, 2016 Category: Journals (General) Source Type: news

Program Helps With Transition to Renal Replacement Therapy Program Helps With Transition to Renal Replacement Therapy
After completion of a program on the transition from late-stage chronic kidney disease to end-stage renal replacement therapy, patients had a better understanding of their treatment options.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 18, 2016 Category: Intensive Care Tags: Nephrology News Source Type: news

Lowering Urate Helps Renal Function
(MedPage Today) -- Most improvement seen in stage 3 chronic kidney disease (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 18, 2016 Category: Journals (General) Source Type: news

Reflux and ulcer medications linked to kidney stones and chronic kidney disease
Certain medications commonly used to treat heartburn, acid reflux, and ulcers can have damaging effects on the kidneys. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 18, 2016 Category: Science Source Type: news

Smoking may hinder kidney disease drugs
HealthDay News Cigarette smoking may decrease the effectiveness of drugs taken during early stages of chronic kidney disease, a small study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 18, 2016 Category: Consumer Health News Source Type: news

Smoking May Hinder Kidney Disease Drugs
FRIDAY, Nov. 18, 2016 -- Cigarette smoking may decrease the effectiveness of drugs taken during early stages of chronic kidney disease, a small study suggests. Blood pressure-lowering drugs known as angiotensin-converting enzyme inhibitors slow... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 18, 2016 Category: Journals (General) Source Type: news

Reducing salt intake may help protect kidney patients ’ heart and kidney health
New research indicates that reducing sodium intake may provide kidney and heart benefits for patients with chronic kidney disease (CKD). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 18, 2016 Category: Science Source Type: news